Levosimendan: a new dual-acting, non-arrhythmoqenic drug in decompensated congestive heart failure New drugs and disease management 12 February 2013 Pages: 1 - 5
Different strategies are needed to manage severe background and procedural burn pain New drugs and disease management 12 February 2013 Pages: 5 - 8
Chlorambucil is still an appropriate first-line therapy for chronic lymphocytic leukaemia New drugs and disease management 12 February 2013 Pages: 8 - 12
Antidepressant discontinuation syndromes: common, under-recognised and not always benign Drug reactions and interactions 12 February 2013 Pages: 12 - 15
First reports of adverse drug reactions (ADRs) in recent weeks Drug reactions and interactions 12 February 2013 Pages: 15 - 15